SFG
ZOM

Sovereign Financial Group’s Zomedica Corp. ZOM Stock Holding History

Sovereign Financial Group’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,750
Closed -$19K – 192
2021
Q2 		$19K Hold
11,750
– – 0.01% 166
2021
Q1 		$19K Buy
+11,750
New +$19.2K 0.01% 166

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sovereign Financial Group's ZOM Position: Q3 2021 in Review

Sovereign Financial Group sold out of Zomedica Corp. (ZOM) in Q3 2021, closing a stake of 11,750 shares — an estimated $19K sold.

Sovereign Financial Group first reported a position in ZOM in Q1 2021 and held it in 2 quarters. The position peaked at $19K in Q2 2021. 107 funds tracked by Wall St. Rank hold ZOM as of Q3 2021.

  • Sovereign Financial Group reported no remaining Zomedica Corp. position as of Q3 2021 after selling out during the quarter.
  • Sovereign Financial Group sold 11,750 Zomedica Corp. shares in Q3 2021, an estimated $19K.
  • Sovereign Financial Group first reported a position in Zomedica Corp. in Q1 2021 and held it in 2 quarters.
  • Sovereign Financial Group's Zomedica Corp. position peaked at $19K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2021.

Based on Sovereign Financial Group's 13F filing for Q3 2021, filed 12 Nov 2021.